professor medical pharmacology neurologist
Verified email at
Cited by
Cited by
Colonic inflammation in Parkinson's disease
D Devos, T Lebouvier, B Lardeux, M Biraud, T Rouaud, H Pouclet, ...
Neurobiology of disease 50, 42-48, 2013
Targeting chelatable iron as a therapeutic modality in Parkinson's disease
D Devos, C Moreau, JC Devedjian, J Kluza, M Petrault, C Laloux, ...
Antioxidants & redox signaling 21 (2), 195-210, 2014
Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC
B Do Van, F Gouel, A Jonneaux, K Timmerman, P Gelé, M Pétrault, ...
Neurobiology of disease 94, 169-178, 2016
The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson’s disease
P Sockeel, K Dujardin, D Devos, C Denève, A Destée, L Defebvre
Journal of Neurology, Neurosurgery & Psychiatry 77 (5), 579-584, 2006
STN-DBS frequency effects on freezing of gait in advanced Parkinson disease
C Moreau, L Defebvre, A Destée, S Bleuse, F Clement, JL Blatt, ...
Neurology 71 (2), 80-84, 2008
Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration
S Masaldan, AI Bush, D Devos, AS Rolland, C Moreau
Free Radical Biology and Medicine 133, 221-233, 2019
Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double‐blind, randomized, placebo‐controlled study
D Devos, K Dujardin, I Poirot, C Moreau, O Cottencin, P Thomas, ...
Movement Disorders 23 (6), 850-857, 2008
Characteristics of apathy in Parkinson's disease
K Dujardin, P Sockeel, D Devos, M Delliaux, P Krystkowiak, A Destée, ...
Movement Disorders 22 (6), 778-784, 2007
Ferroptosis and its potential role in the physiopathology of Parkinson’s Disease
L Mahoney-Sánchez, H Bouchaoui, S Ayton, D Devos, JA Duce, ...
Progress in neurobiology 196, 101890, 2021
Clinical quantitative susceptibility mapping (QSM): biometal imaging and its emerging roles in patient care
Y Wang, P Spincemaille, Z Liu, A Dimov, K Deh, J Li, Y Zhang, Y Yao, ...
Journal of magnetic resonance imaging 46 (4), 951-971, 2017
Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease
D Devos, French DUODOPA Study Group
Movement Disorders 24 (7), 993-1000, 2009
Study of circadian melatonin secretion pattern at different stages of Parkinson's disease
R Bordet, D Devos, S Brique, Y Touitou, JD Guieu, C Libersa, A Destee
Clinical neuropharmacology 26 (2), 65-72, 2003
Platelet microparticles: detection and assessment of their paradoxical functional roles in disease and regenerative medicine
T Burnouf, HA Goubran, ML Chou, D Devos, M Radosevic
Blood reviews 28 (4), 155-166, 2014
Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo …
C Moreau, A Delval, L Defebvre, K Dujardin, A Duhamel, G Petyt, ...
The lancet neurology 11 (7), 589-596, 2012
Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial
D Devos, C Moreau, D Maltête, R Lefaucheur, A Kreisler, A Eusebio, ...
Journal of Neurology, Neurosurgery & Psychiatry 85 (6), 668-674, 2014
Elevated IL-6 and TNF-α levels in patients with ALS: inflammation or hypoxia?
C Moreau, D Devos, V Brunaud-Danel, L Defebvre, T Perez, A Destee, ...
Neurology 65 (12), 1958-1960, 2005
Brief and sustained movements: differences in event-related (de) synchronization (ERD/ERS) patterns
F Cassim, W Szurhaj, H Sediri, D Devos, JL Bourriez, I Poirot, ...
Clinical neurophysiology 111 (11), 2032-2039, 2000
Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson’s disease
D Devos, P Krystkowiak, F Clement, K Dujardin, O Cottencin, ...
Journal of Neurology, Neurosurgery & Psychiatry 78 (5), 470-475, 2007
A specific clinical pattern of camptocormia in Parkinson’s disease
AC Lepoutre, D Devos, A Blanchard-Dauphin, V Pardessus, CA Maurage, ...
Journal of Neurology, Neurosurgery & Psychiatry 77 (11), 1229-1234, 2006
Apathy in Parkinson's disease is associated with nucleus accumbens atrophy: a magnetic resonance imaging shape analysis
N Carriere, P Besson, K Dujardin, A Duhamel, L Defebvre, C Delmaire, ...
Movement disorders 29 (7), 897-903, 2014
The system can't perform the operation now. Try again later.
Articles 1–20